Depixus: Depixus Unveils MAGNA One: World's First Laboratory Instrument for Analyzing Individual Biomolecular Interactions at Scale

Press Release: Depixus : New Study Demonstrates Power of Depixus' Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development

Depixus: Depixus wins SLAS2024 Ignite Award for MAGNA technology

Depixus: Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA Technology

Depixus: Depixus Launches Technology Access Program With First MAGNA One Instrument Placement

Depixus: French firm Depixus collaborates with Japan's Daiichi Sankyo to accelerate RNA-targeted drug discovery, Read more

Depixus: Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target

Depixus: Depixus' 30.6 Million Series A Financing

Depixus: Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Depixus: Depixus announces peer-reviewed publication describing the detection of sequence variation and base modifications on DNA and RNA using its novel MAGNATM technology